Discover our impact all over the world.

Numbers displayed on the map are a representation of the activity in each country. Once you use the filter selections below, you will have the opportunity to explore projects and faculty in each country.

Projects + Faculty = Activity Number

##

Overview

Projects 699
Countries 138
Faculty 432
Health Topics 132

Filter from the selections below

Clear All Filters

Targeted Long-acting Antiretroviral Therapy (TLC-ART)

Adapt primers from "HIV drug-resistance Illumina assay using Template IDs to quantify resistant variants” to SHIV. Optimize sensitivity to 0.5-1% and determine blood and lymph node specimen input needed for reproducibility within <1% to quantify mutations to FTC, TDF, LPV/rt and RAL. Test SHIV for resistance mutations to FTC, TDF, LPV/rt and RAL in 4 specimens (blood from pre-ART, 1, 2, 3, and 4 weeks and lymph node + gut from necropsy) from each of 18 monkeys.

Countries 
Active Dates 
07/01/2017 to 06/30/2020
Faculty Involved